GlassScriptPhysician profile
Travis C Taylor
NPI 1437266582
$790.70
in general payments reported to CMS, 2019-2025
10 companies · $115 in 2025
The $115 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.67 · 2021: $49.23 · 2022: $148 · 2023: $246 · 2024: $201 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $293.68 | 2021-2025 | Puraply, Apligraf, Cygnus Dual |
| Smith+Nephew, INC. | $242.72 | 2021-2025 | Collagenase Santyl, Renasys Go V2 Home, Renasys Touch |
| Tactile Systems Technology INC | $81.39 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Convatec INC. | $45.56 | 2022-2023 | |
| Misonix INC | $31.67 | 2020 | |
| Urgo Medical North America, LLC | $21.57 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Cashflow Solutions, LLC | $21.55 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Solventum Corporation | $17.88 | 2024 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Integra Lifesciences Corporation | $17.58 | 2023 | Tcc-Ez |
| Kerecis Limited | $17.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.